Acute myocardial infarction in a patient with post-splenectomy thrombocytosis: A case report and review of literature by Ghaffari, Samad & Pourafkari, Leili
www.cardiologyjournal.org 79
CASE REPORT
Cardiology Journal
2010, Vol. 17, No. 1, pp. 79–82
Copyright © 2010 Via Medica
ISSN 1897–5593
Address for correspondence: Leili Pourafkari, MD, Cardiovascular Research, Department of Tabriz University of Medical
Sciences, Madani Heart Hospital, Tabriz, Iran, tel./fax: +98 (411) 335 77 70, e-mail: leili.p@gmail.com
Received: 10.02.2009 Accepted: 15.04.2009
Acute myocardial infarction in a patient
with post-splenectomy thrombocytosis:
A case report and review of literature
Samad Ghaffari, Leili Pourafkari
Cardiovascular Research Department of Tabriz University of Medical Sciences,
Madani Heart Center, Tabriz, Iran
Abstract
Unlike essential thrombocytosis, which is associated with thrombotic and hemorrhagic compli-
cations, reactive thrombocytosis (RT) is usually considered a benign process without throm-
botic complications.
We describe a case of acute myocardial infarction in a young heavy smoker with RT following
splenectomy. Coronary angiography showed a linear filling defect at mid-part of left anterior
descending artery. We performed balloon angioplasty and stenting for this lesion. Aspirin and
clopidogrel were administered. His in-hospital course was uneventful and platelet count re-
turned to the normal range at four month follow-up. We concluded that RT may not be an
entirely benign process, especially in patients with a history of smoking. Regular monitoring of
platelet count, and possibly antithrombotic agents like aspirin prescription for high risk pa-
tients with moderate thrombocytosis, may be useful. (Cardiol J 2010; 17, 1: 79–82)
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Introduction
Thrombocytosis, often found incidentally, is
most commonly a reactive or secondary response
to chronic inflammation, iron deficiency, active
malignancy, infection, trauma, or splenectomy [1].
In a small number of cases however, thrombocyto-
sis may be attributable to a clonal process, such as
one of the four well-described classic myeloprolif-
erative disorders: chronic myelogenous leukemia,
polycythemia vera (PV), agnogenic myeloid meta-
plasia, and essential thrombocytosis (ET). Throm-
bocytosis is a rare cause of myocardial infarction in
patients with intrinsically normal coronary arteries,
and especially very rare in patients with reactive
thrombocytosis [2].
Case report
A 34 year-old male presented to the emergen-
cy department with acute retrosternal chest pain
radiating to his left arm associated with cold sweat
and nausea which woke him at 4 am, three hours
before his arrival at emergency department. He had
undergone distal pancreatectomy with splenecto-
my, for chronic pancreatitis and pancreatic pseudo-
cysts 12 days earlier. His past medical history also
included migraine headaches. He had also been
a heavy smoker. He didn’t have a family history of
coronary artery disease. He had a blood pressure
of 130/80 mm Hg, and  heart rate of 80/min. His
physical examination showed no pathological find-
ings except for a recent laparatomy scar. His first
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electrocardiogram at the time of admission showed
ST segment elevation of 3–4 mm in precordial leads
(Fig. 1). The patient received a loading dose of as-
pirin 325 mg and clopidogrel 300 mg orally, heparin
5000 IU bolus IV injection, metoprolol 50 mg, ator-
vastatin 40 mg and was also placed on nitroglycer-
in and heparin infusion. Thrombolytic therapy was
not administered as it was contraindicated for his
recent major surgery history. His laboratory tests
showed Hgb = 12.5 mg/dL, WBC = 11 000/mL,
PLT = 792 000//mL, CK-MB = 110, cTNI = 8,
ESR = 34, CRP: 1+ and the rest of routine labora-
tory studies were within normal limits. Further
work-up for iron deficiency anemia was negative.
Bedside echocardiography showed left ventricular
ejection fraction of 40% with hypokinesia of anteri-
or wall and apical segments. He underwent coro-
nary angiography which showed a linear filling de-
fect at mid-portion of left anterior descending ar-
tery (Fig. 2) which was treated with low pressure
balloon inflation and then a 3 × 15 ProkinetikTM
(Biotronik, Buelach, Switzerland) bare metal stent
was deployed. His hospital course was uneventful
and he was discharged in a stable condition on as-
pirin 325 mg, clopidogrel 75 mg, metoprolol 100 mg
and atorvastatin 40 mg daily on the fifth day follow-
ing admission. At four month follow-up the patient’s
general condition was good, left ventricular ejection
fraction was about 50% and his platelet count was
410 × 103/mL.
Discussion
Thrombosis represents the second highest
cause of mortality in patients with PV or ET [3]. In
published series, the rate of cardiovascular compli-
cations related to the presence of ET has ranged
from 4% to 21%. Thrombosis, when it occurs, is
more common in the arterial vascular bed (75%)
than in the venous circulation (25%) [4]. The overall
risk of thrombotic events in ET, which may include
myocardial infarction, stroke, pulmonary embolism,
deep vein thrombosis, transient ischemic attack,
retinal artery or venous occlusions, hepatic or por-
tal vein thrombosis, and digital ischemia, has been
found to be 6.6% per patient per year, in comparison
to 1.2% per patient per year in the control popula-
tion. Paradoxically, patients with ET are prone to
hemorrhagic complications. Bleeding tends to oc-
cur spontaneously in superficial sites such as the
skin and mucus membranes as well as the gastro-
intestinal or respiratory tracts [5].
Conversely, reactive thrombocytosis is a be-
nign process and is not a risk factor for thromboem-
bolic complications [6]. In the immediate post-op-
erative period in uncomplicated splenectomy pa-
tients, the platelet count rises steeply with a peak
Figure 1. Electrocardiography shows ST segment ele-
vations in leads V1–V5.
Figure 2. Left anterior oblique view of left coronary sys-
tem. Linear filling defect indicating thrombosis is seen
within the left anterior descending (arrow).
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value at seven to 12 days. It usually subsides over
the next two to three months. However in some
patients the thrombocytosis persists indefinitely
following splenectomy [1].
In a large retrospective study of 732 patients
with thrombocytosis, 87.7% had reactive thrombo-
cytosis. Thromboembolic complications were re-
ported in 12.4% of patients with primary thrombo-
cytosis compared with 1.6% in patients with reac-
tive thrombocytosis. All patients with secondary
thrombocytosis developing thrombotic complica-
tions had additional risk factors such as preceding
surgery or a co-existing malignancy [7]. In one large
retrospective study comprising 318 patients with-
out myeloproliferative disorders who underwent
splenectomy, thrombocytosis developed in 75% of
the patients without a substantial increase in the
incidence of thromboembolic events [8]. On the
other hand, in a retrospective study of 129 patients
with platelet counts of 1,000 × 109/L or more, Buss
et al. [9] reported an equal frequency of thrombotic
events among patients with myeloproliferative dis-
orders and those with reactive thrombocytosis. In
a retrospective study evaluating 80 splenectomized
patients suffering from various types of hereditary
hemolytic anemia, sideroblastic anemia, hemoglob-
inopathies, or thalassemia, Hirsh and Dacie found
that 13% developed thromboembolic complications
in association with persistent postsplenectomy
thrombocytosis, two of whom died from these com-
plications a long time after splenectomy. Howev-
er, the authors suggested that post-splenectomy
thrombocytosis should not be the only factor pre-
disposing patients to thrombosis because many
patients from their own series have had compara-
ble increases in the post-splenectomy platelet count
that have been maintained for many years and have
not developed signs of thromboembolism [10].
To our knowledge, this is the third reported
case of acute myocardial infarction in patients with
reactive thrombocytosis [11, 12]. Our patient re-
fused bone marrow biopsy. However, normal count
of platelets at the time of surgery (256 × 103) with
a dramatic rise to 792 × 103 on the twelfth post-
operative day, together with the gradual decline to
normal range during the next four months favor
reactive thrombocytosis. Also, studies to evaluate
a hypercoagulable state and iron deficiency anemia
including factor V Leiden mutation, protein C and S,
antithrombin activity and homocystein and fibrino-
gen levels, together with lupus anticoagulant, anti-
cardiolipin and anti beta II glycoprotein I antibod-
ies were all negative. Coronary angiography showed
a linear filling defect at mid-part of left anterior
descending artery consistent with a thrombosis.
While coronary occlusion due to ET may occur as
a result of thrombotic aggregation on the damaged
endothelium in totally normal coronary arteries, it
also could be due to the thrombotic material aggre-
gation over the atherosclerotic lesions resulting in
stenosis of unimportance [13]. During angioplasty,
the balloon was fully expanded at very low inflation
pressure of about 1–2 atmospheres and in coronary
angiography images acquired just after this inflation
there was no residual stenosis. This may indicate
lack of any atherosclerotic stenosis in our patient’s
coronary tree. Our patient had a history of smok-
ing which has been shown to be common in young
patients with infarction and ET [14]. His past med-
ical history also included migraine headaches which
are reported to be associated with vascular reactiv-
ity and this may be an appropriate substrate for in
situ thrombus formation [15].
Our case demonstrates the potential for a ma-
jor vascular event in the setting of reactive throm-
bocytosis, especially in those with a history of
smoking. While the preventive effect of anti-coa-
gulant and anti-platelets drugs has not been well-
-established, regular monitoring of platelet count and
possibly antithrombotic agents like aspirin prescrip-
tion for high risk patients with moderate thrombo-
cytosis may be useful. Due to a very low event rate
in this setting, large studies are needed to evaluate
this hypothesis.
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